# Definium Therapeutics, Inc.: Form 8-K, filed Aug 12, 2026

- Company: [Definium Therapeutics, Inc.](/companies/dftx.md) (CIK 1813814)
- Form: 8-K
- Filed: 2026-08-12
- Accepted by EDGAR: Aug 12, 2026, 08:05 ET
- Period: 2026-08-12
- Accession: 0001104659-26-094528
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1813814/000110465926094528/tm2622948d1_8k.htm

Filed Aug 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-094528. Last ingested by Listed: Nov 14, 2026, 13:59 ET. No prices; not investment advice.
